4-nitroquinoline-1-oxide has been researched along with aphidicolin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Edwards, S; Fielding, S; Waters, R | 1 |
Dietrich, K; Mirzayans, R; Paterson, MC | 1 |
Hartmann, A; Speit, G | 1 |
Furuichi, Y; Goto, M; Heo, SJ; Nishikawa, K; Sakamoto, S; Shimamoto, A | 1 |
4 other study(ies) available for 4-nitroquinoline-1-oxide and aphidicolin
Article | Year |
---|---|
The response to DNA damage induced by 4-nitroquinoline-1-oxide or its 3-methyl derivative in xeroderma pigmentosum fibroblasts belonging to different complementation groups: evidence for different epistasis groups involved in the repair of large adducts i
Topics: 4-Nitroquinoline-1-oxide; Aphidicolin; Catalase; Cell Line; Diterpenes; DNA Damage; DNA Repair; Epistasis, Genetic; Fibroblasts; Humans; Mutagens; Nitroquinolines; Xeroderma Pigmentosum | 1987 |
Aphidicolin and 1-beta-D-arabinofuranosylcytosine strongly inhibit transcriptionally active DNA repair in normal human fibroblasts.
Topics: 4-Nitroquinoline-1-oxide; Aphidicolin; Cell Line; Cytarabine; DNA Repair; Fibroblasts; Genes, myc; Humans; Mutagens; Transcription, Genetic; Ultraviolet Rays | 1993 |
The contribution of excision repair to the DNA effects seen in the alkaline single cell gel test (comet assay).
Topics: 4-Nitroquinoline-1-oxide; 9,10-Dimethyl-1,2-benzanthracene; Aphidicolin; Benzo(a)pyrene; Cell Survival; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Enzyme Inhibitors; Fibroblasts; Humans; Male; Mutagens; Ultraviolet Rays; Xeroderma Pigmentosum | 1995 |
Werner helicase relocates into nuclear foci in response to DNA damaging agents and co-localizes with RPA and Rad51.
Topics: 4-Nitroquinoline-1-oxide; Aphidicolin; Bleomycin; Camptothecin; Cell Line; Cell Nucleus; DNA Damage; DNA Helicases; DNA Replication; DNA-Binding Proteins; Dose-Response Relationship, Drug; Etoposide; Humans; Immunoblotting; Immunohistochemistry; In Situ Hybridization, Fluorescence; Mutagens; Proteins; Rad51 Recombinase; Trans-Activators; Werner Syndrome | 2001 |